Investors are on the edge of their collective seats, hoping that Quaker Chemical
What analysts say:
- Buy, sell, or hold?: Analysts strongly back Quaker Chemical, with three of four rating it a buy and the remainder rating it a hold. That rating hasn't budged in three months as analysts have remained unchanged in their opinion of the stock.
- Revenue forecasts: On average, analysts predict $173.8 million in revenue this quarter. That would represent a rise of 22.3% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.79 per share. Estimates range from $0.75 to $0.80.
What our community says:
CAPS All-Stars are in strong support of the stock, with 100% awarding it an "outperform" rating. Most of the community backs the All-Stars, with 97.1% granting it a rating of "outperform." Quaker Chemical has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.
Quaker Chemical's profit has risen year over year by an average of 29.4% over the past five quarters. Revenue has now gone up for three straight quarters. The company's gross margin shrank by three percentage points in the last quarter. Revenue rose 32.4% while cost of sales rose 38.6% to $122.8 million from a year earlier.
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Quaker Chemical now.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.